Zkusit zdarma
Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings, Inc.

RANI
Cena:
$ 1.07
0.00 (0.00%)
Valuace
70
Růst
53
Zdraví
69
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition

Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition

16:05 15-05-2026

- Continued advancement of the ongoing Phase 1 study of RT-114 via RaniPill® for the treatment of o...

Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference

Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference

16:05 12-05-2026

SAN JOSE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therape...

Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy

Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy

7:00 09-04-2026

SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Thera...

Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript

Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript

20:15 26-03-2026

Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript...

Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization

Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization

16:53 25-03-2026

SAN JOSE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Thera...

Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results

Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results

16:05 19-03-2026

SAN JOSE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Thera...

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Recommendation of “Moderate Buy” from Brokerages

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Recommendation of “Moderate Buy” from Brokerages

3:12 22-02-2026

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI - Get Free Report) has earned an average recommendati...

Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer

Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer

7:00 28-01-2026

SAN JOSE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therap...

Rani Therapeutics (NASDAQ:RANI) Stock Price Down 2.2% – What’s Next?

Rani Therapeutics (NASDAQ:RANI) Stock Price Down 2.2% – What’s Next?

1:32 31-12-2025

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI - Get Free Report)'s share price fell 2.2% during mid...

Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update

Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update

16:30 06-11-2025

– Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-va...

Rani Therapeutics Sees Unusually Large Options Volume (NASDAQ:RANI)

Rani Therapeutics Sees Unusually Large Options Volume (NASDAQ:RANI)

1:18 05-11-2025

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI - Get Free Report) was the target of some unusual opt...

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025

8:00 30-10-2025

SAN JOSE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therap...

Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

16:05 23-10-2025

SAN JOSE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therap...

Rani Therapeutics: Initiating At Buy On Promising RaniPill Advancement With Chugai

Rani Therapeutics: Initiating At Buy On Promising RaniPill Advancement With Chugai

14:20 20-10-2025

Rani Therapeutics is initiated at a Buy rating, driven by major pipeline advancements and strong par...

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma

7:48 17-10-2025

Rani Therapeutics said on Friday it has agreed a deal to license an oral drug to Japan's Chugai Phar...

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

7:30 17-10-2025

SAN JOSE, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therap...

Rani (RANI) Q2 Net Loss Improves 16%

Rani (RANI) Q2 Net Loss Improves 16%

16:35 07-08-2025

Rani Therapeutics (RANI -3.04%), a biotech company developing oral biologic drug delivery technology...

Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update

Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update

16:05 07-08-2025

– Announced strategic research collaboration with Chugai for two undisclosed molecules – – Pre...

Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering

Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering

9:00 15-07-2025

SAN JOSE, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therap...

Rani Therapeutics Announces Research Agreement with Chugai

Rani Therapeutics Announces Research Agreement with Chugai

8:00 19-05-2025

- Research agreement is evaluating feasibility of applying Rani's oral delivery technology to Chuga...

close

RANI THERAPEUTICS ANNOUNCES THE PROMOTION OF ALIREZA JAVADI, PH.D. TO CHIEF TECHNICAL OFFICER

28-01-2026
SAN JOSE, CALIF., JAN. 28, 2026 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAP...
Více zde

RANI THERAPEUTICS INITIATES PHASE 1 STUDY OF RT-114 RANIPILL® FOR THE TREATMENT OF OBESITY IN COLLABORATION WITH PROGEN

08-01-2026
- A PHASE 1 STUDY TO EVALUATE SAFETY, TOLERABILITY, BIOAVAILABILITY, PHARMACOKINETICS, AND WEIGHT LO...
Více zde

RANI THERAPEUTICS TO PARTICIPATE IN THE EVERCORE HEALTHCARE CONFERENCE

24-11-2025
SAN JOSE, CALIF., NOV. 24, 2025 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAP...
Více zde

RANI THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS; PROVIDES CORPORATE UPDATE

06-11-2025
– ANNOUNCED UP TO $1.085 BILLION COLLABORATION WITH CHUGAI PHARMACEUTICAL CO. FOR MULTIPLE HIGH-VA...
Více zde

RANI THERAPEUTICS TO PRESENT PRECLINICAL DATA ON ORAL DELIVERY OF SEMAGLUTIDE VIA THE RANIPILL® CAPSULE AT OBESITYWEEK® 2025

30-10-2025
SAN JOSE, CALIF., OCT. 30, 2025 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAP...
Více zde

RANI THERAPEUTICS ANNOUNCES THE APPOINTMENTS OF ABE BASSAN AND VASUDEV BAILEY, PH.D. TO BOARD OF DIRECTORS

23-10-2025
SAN JOSE, CALIF., OCT. 23, 2025 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAP...
Více zde

RANI THERAPEUTICS ANNOUNCES CLOSING OF OVERSUBSCRIBED $60.3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES

23-10-2025
FINANCING LED BY SAMSARA BIOCAPITAL, L.P. (“SAMSARA”) WITH PARTICIPATION FROM ADDITIONAL INVESTO...
Více zde

RANI THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $60.3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES

17-10-2025
SAN JOSE, CALIF., OCT. 17, 2025 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAP...
Více zde

RANI THERAPEUTICS ANNOUNCES UP TO $1.085 BILLION COLLABORATION WITH CHUGAI PHARMACEUTICAL CO. FOR MULTIPLE HIGH-VALUE THERAPEUTICS INCLUDING RARE DISEASE AND IMMUNOLOGY PROGRAMS AND ANNOUNCES CONCURRENT OVERSUBSCRIBED $60.3 MILLION FINANCING

17-10-2025
SAN JOSE, CALIF., OCT. 17, 2025 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAP...
Více zde

RANI THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS; PROVIDES CORPORATE UPDATE

07-08-2025
– ANNOUNCED STRATEGIC RESEARCH COLLABORATION WITH CHUGAI FOR TWO UNDISCLOSED MOLECULES – – PRE...
Více zde

RANI THERAPEUTICS HOLDINGS, INC. ANNOUNCES PRICING OF $3.0 MILLION REGISTERED DIRECT OFFERING

15-07-2025
SAN JOSE, CALIF., JULY 15, 2025 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAP...
Více zde

RANI THERAPEUTICS AND PROGEN ANNOUNCE LATE BREAKING PRESENTATION AT ENDO 2025 DEMONSTRATING BIOEQUIVALENCE OF NOVEL, BISPECIFIC GLP-1/GLP-2 RECEPTOR AGONIST DELIVERED ORALLY VIA RANIPILL COMPARED TO SUBCUTANEOUS DELIVERY

14-07-2025
SAN JOSE, CALIF., JULY 14, 2025 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAP...
Více zde

RANI THERAPEUTICS ANNOUNCES RESEARCH AGREEMENT WITH CHUGAI

19-05-2025
- RESEARCH AGREEMENT IS EVALUATING FEASIBILITY OF APPLYING RANI'S ORAL DELIVERY TECHNOLOGY TO CHUGA...
Více zde

RANI THERAPEUTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS; PROVIDES CORPORATE UPDATE

13-05-2025
- ANNOUNCED PRECLINICAL DATA DEMONSTRATING THE BIOEQUIVALENCE OF RT-114, A BISPECIFIC GLP-1/GLP-2 RE...
Více zde

RANI THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS; PROVIDES CORPORATE UPDATE

31-03-2025
- ANNOUNCED PRECLINICAL DATA DEMONSTRATING THE BIOEQUIVALENCE OF RT-114, A GLP-1/GLP-2 DUAL AGONIST ...
Více zde

RANI THERAPEUTICS ANNOUNCES PRECLINICAL DATA DEMONSTRATING BIOEQUIVALENCE OF RT-114, A GLP-1/GLP-2 DUAL AGONIST (PG-102) DELIVERED ORALLY VIA THE RANIPILL® CAPSULE, TO SUBCUTANEOUSLY ADMINISTERED PG-102

26-03-2025
- RT-114 YIELDED A RELATIVE BIOAVAILABILITY OF 111% COMPARED TO PG-102 DELIVERED SUBCUTANEOUSLY WITH...
Více zde

RANI THERAPEUTICS TO REPORT FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

25-03-2025
SAN JOSE, CALIF., MARCH 25, 2025 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERA...
Více zde

RANI THERAPEUTICS HOLDINGS, INC. ANNOUNCES PRICING OF $10.0 MILLION REGISTERED DIRECT OFFERING AND CANCELLATION OF CERTAIN EXISTING WARRANTS

15-10-2024
SAN JOSE, CALIF., OCT. 15, 2024 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAP...
Více zde

RANI THERAPEUTICS TO PARTICIPATE IN THE 2024 MAXIM HEALTHCARE VIRTUAL SUMMIT

08-10-2024
SAN JOSE, CALIF., OCT. 08, 2024 (GLOBE NEWSWIRE) --  RANI THERAPEUTICS HOLDINGS, INC. (“RANI THER...
Více zde

RANI THERAPEUTICS TO PARTICIPATE IN SEPTEMBER INVESTOR CONFERENCES

03-09-2024
SAN JOSE, CALIF., SEPT. 03, 2024 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERA...
Více zde

RANI THERAPEUTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS; PROVIDES CORPORATE UPDATE

06-08-2024
- ANNOUNCED PARTNERSHIP WITH PROGEN ON DEVELOPMENT OF RT-114, AN ORAL GLP-1/GLP-2 DUAL AGONIST FOR T...
Více zde

RANI THERAPEUTICS TO PARTICIPATE IN AUGUST INVESTOR CONFERENCES

29-07-2024
SAN JOSE, CALIF., JULY 29, 2024 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAP...
Více zde

RANI THERAPEUTICS HOLDINGS, INC. ANNOUNCES PRICING OF $10.0 MILLION REGISTERED DIRECT OFFERING

22-07-2024
SAN JOSE, CALIF., JULY 22, 2024 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAP...
Více zde

RANI THERAPEUTICS ANNOUNCES PARTNERSHIP WITH PROGEN ON DEVELOPMENT OF ORAL OBESITY TREATMENT

24-06-2024
~ NEW RT-114 OBESITY PROGRAM COMBINES PROGEN'S FC FUSION PROTEIN CONJUGATED GLP-1/GLP-2 DUAL AGONIST...
Více zde

RANI THERAPEUTICS TO PARTICIPATE IN MAY INVESTOR CONFERENCES

14-05-2024
SAN JOSE, CALIF., MAY 14, 2024 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAPE...
Více zde

RANI THERAPEUTICS TO PRESENT CLINICAL AND PRECLINICAL DATA ON ORAL DELIVERY OF AN USTEKINUMAB BIOSIMILAR VIA THE RANIPILL® CAPSULE AT DIGESTIVE DISEASE WEEK 2024

09-05-2024
SAN JOSE, CALIF., MAY 09, 2024 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERAPE...
Více zde

RANI THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS; PROVIDES CORPORATE UPDATE

06-05-2024
- ANNOUNCED POSITIVE TOPLINE RESULTS FROM PHASE 1 STUDY OF AN ORAL ANTI-INTERLEUKIN 12/23 ANTIBODY (...
Více zde

RANI THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS; PROVIDES CORPORATE UPDATE

20-03-2024
- ANNOUNCED POSITIVE TOPLINE RESULTS FROM PHASE 1 STUDY OF AN ORAL ANTI-INTERLEUKIN 12/23 ANTIBODY (...
Více zde

RANI THERAPEUTICS TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

15-03-2024
SAN JOSE, CALIF., MARCH 15, 2024 (GLOBE NEWSWIRE) -- RANI THERAPEUTICS HOLDINGS, INC. (“RANI THERA...
Více zde

SHAREHOLDER ALERT: PURCELL & LEFKOWITZ LLP ANNOUNCES SHAREHOLDER INVESTIGATION OF RANI THERAPEUTICS HOLDINGS, INC. (NASDAQ: RANI)

09-01-2024
NEW YORK , JAN. 9, 2024 /PRNEWSWIRE/ -- PURCELL & LEFKOWITZ LLP ANNOUNCES THAT IT IS INVESTIGATING R...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-02 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-10-27 00:00:008-KStáhnout
2025-10-17 01:00:008-KStáhnout
2025-10-17 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-07-16 01:00:008-KStáhnout
2025-07-16 00:00:008-KStáhnout
2025-06-26 01:00:008-KStáhnout
2025-06-26 00:00:008-KStáhnout
2025-05-29 01:00:008-KStáhnout
2025-05-29 00:00:008-KStáhnout
2025-05-20 01:00:008-KStáhnout
2025-05-20 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 01:00:0010-QStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-13 00:00:0010-QStáhnout
2025-05-06 01:00:008-KStáhnout
2025-05-06 00:00:008-KStáhnout
2025-04-30 01:00:008-KStáhnout
2025-04-30 00:00:008-KStáhnout
2025-04-09 01:00:008-KStáhnout
2025-04-09 00:00:008-KStáhnout
2025-03-31 01:00:008-KStáhnout
2025-03-31 01:00:0010-KStáhnout
2025-03-31 00:00:008-KStáhnout
2025-03-31 00:00:0010-KStáhnout
2024-11-14 00:00:008-KStáhnout
2024-11-14 00:00:0010-QStáhnout
2024-11-13 23:00:008-KStáhnout
2024-11-13 23:00:0010-QStáhnout
2024-10-16 01:00:008-KStáhnout
2024-10-16 00:00:008-KStáhnout
2024-09-11 01:00:008-KStáhnout
2024-09-11 00:00:008-KStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 01:00:0010-QStáhnout
2024-08-06 00:00:008-KStáhnout
2024-08-06 00:00:0010-QStáhnout
2024-07-23 01:00:008-KStáhnout
2024-07-23 00:00:008-KStáhnout
2024-07-12 01:00:008-KStáhnout
2024-07-12 00:00:008-KStáhnout
2024-06-24 01:00:008-KStáhnout
2024-06-24 00:00:008-KStáhnout
2024-05-30 01:00:008-KStáhnout
2024-05-30 00:00:008-KStáhnout
2024-05-06 01:00:008-KStáhnout
2024-05-06 01:00:0010-QStáhnout
2024-05-06 00:00:008-KStáhnout
2024-05-06 00:00:0010-QStáhnout
2024-03-20 00:00:008-KStáhnout
2024-03-20 00:00:0010-KStáhnout
2024-03-19 23:00:008-KStáhnout
2024-03-19 23:00:0010-KStáhnout
2024-02-05 00:00:008-KStáhnout
2024-02-04 23:00:008-KStáhnout
2023-12-19 00:00:008-KStáhnout
2023-12-18 23:00:008-KStáhnout
2023-12-14 00:00:008-KStáhnout
2023-12-13 23:00:008-KStáhnout
2023-11-08 00:00:008-KStáhnout
2023-11-08 00:00:0010-QStáhnout
2023-11-07 23:00:008-KStáhnout
2023-11-07 23:00:0010-QStáhnout
2023-11-01 00:00:008-KStáhnout
2023-10-31 23:00:008-KStáhnout
2023-10-25 01:00:008-KStáhnout
2023-10-25 00:00:008-KStáhnout
2023-09-07 01:00:008-KStáhnout
2023-09-07 00:00:008-KStáhnout
2023-08-11 01:00:008-KStáhnout
2023-08-11 01:00:0010-QStáhnout
2023-08-11 00:00:008-KStáhnout
2023-08-11 00:00:0010-QStáhnout
2023-06-05 01:00:008-KStáhnout
2023-06-05 00:00:008-KStáhnout
2023-05-30 01:00:008-KStáhnout
2023-05-30 00:00:008-KStáhnout
2023-05-10 01:00:008-KStáhnout
2023-05-10 01:00:0010-QStáhnout
2023-05-10 00:00:008-KStáhnout
2023-05-10 00:00:0010-QStáhnout
2023-04-05 01:00:008-KStáhnout
2023-04-05 00:00:008-KStáhnout
2023-03-22 00:00:008-KStáhnout
2023-03-22 00:00:0010-KStáhnout
2023-03-21 23:00:008-KStáhnout
2023-03-21 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2023-01-05 00:00:008-KStáhnout
2023-01-04 23:00:008-KStáhnout
2022-12-30 00:00:008-KStáhnout
2022-12-29 23:00:008-KStáhnout
2022-12-06 00:00:008-KStáhnout
2022-12-05 23:00:008-KStáhnout
2022-11-10 00:00:008-KStáhnout
2022-11-10 00:00:0010-QStáhnout
2022-11-09 23:00:008-KStáhnout
2022-11-09 23:00:0010-QStáhnout
2022-10-24 01:00:008-KStáhnout
2022-10-24 00:00:008-KStáhnout
2022-08-25 01:00:008-KStáhnout
2022-08-25 00:00:008-KStáhnout
2022-08-10 01:00:008-KStáhnout
2022-08-10 01:00:0010-QStáhnout
2022-08-10 00:00:008-KStáhnout
2022-08-10 00:00:0010-QStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 00:00:008-KStáhnout
2022-05-26 01:00:008-KStáhnout
2022-05-26 00:00:008-KStáhnout
2022-05-11 01:00:008-KStáhnout
2022-05-11 01:00:0010-QStáhnout
2022-05-11 00:00:008-KStáhnout
2022-05-11 00:00:0010-QStáhnout
2022-03-31 01:00:0010-KStáhnout
2022-03-31 00:00:0010-KStáhnout
2022-03-29 01:00:008-KStáhnout
2022-03-29 00:00:008-KStáhnout
2022-03-23 00:00:008-KStáhnout
2022-03-22 23:00:008-KStáhnout
2022-02-23 00:00:008-KStáhnout
2022-02-22 23:00:008-KStáhnout
2022-01-05 00:00:008-KStáhnout
2022-01-04 23:00:008-KStáhnout
2021-11-16 00:00:008-KStáhnout
2021-11-16 00:00:0010-QStáhnout
2021-11-15 23:00:008-KStáhnout
2021-11-15 23:00:0010-QStáhnout
2021-11-12 00:00:008-KStáhnout
2021-11-11 23:00:008-KStáhnout
2021-09-29 01:00:008-KStáhnout
2021-09-29 00:00:008-KStáhnout
2021-09-13 01:00:008-KStáhnout
2021-09-13 01:00:0010-QStáhnout
2021-09-13 00:00:008-KStáhnout
2021-09-13 00:00:0010-QStáhnout
preloader